Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
Overview
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
Full Title of Study: “Development of Clinical Database of Individuals With Smith-Magenis Syndrome”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: December 2030
Interventions
- Other: Data collection of sleep disturbances in individuals with SMS
- Data related to Smith-Magenis syndrome and sleep disturbances are collected through a web or phone survey
Clinical Trial Outcome Measures
Primary Measures
- Number of individuals with Smith- Magenis syndrome
- Time Frame: 5 years
Secondary Measures
- Sleep Disturbances
- Time Frame: Up to 100 weeks
Participating in This Clinical Trial
Inclusion Criteria
- Parent or legal guardian of individual with Smith-Magenis Syndrome Exclusion Criteria:
- Not legal guardian of individual with SMS
Gender Eligibility: All
Minimum Age: 3 Years
Maximum Age: 65 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Vanda Pharmaceuticals
- Provider of Information About this Clinical Study
- Sponsor
- Overall Contact(s)
- Vanda Pharmaceuticals, 202-734-3400, clinicaltrials@vandapharma.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.